A Personalized Approach to Adjuvant Therapy: Cytoplasmic HuR Status Predicts Disease Free Survival After Resection for Pancreatic Ductal Adenocarcinoma

Authors

• Charles Yeo

Publication/Presentation Date

4-2016

Volume

150

Issue

4

First Page

1211

Last Page

1211

Published In/Presented At

10.1016/S0016-5085(16)34095-1

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article